Alok Vyas - Concepedia

Author

Alok Vyas

Savitribai Phule Pune University

Also Known As

Alok Vyas, Vyas, Alok

Publications

751

Citations

H-Index

Concepts

All Affiliations

Savitribai Phule Pune University Wayne State University The Barbara Ann Karmanos Cancer Institute Lincoln University - Missouri Missouri University of Science and Technology

About

Alok Vyas is an author at Savitribai Phule Pune University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	580
2	Natural Sciences	2	2	135
3	Biochemistry	1	1	38
4	Biomolecular Engineering	1	1	21
5	Cell Biology	1	1	123

Alok Vyas

Publications

624

Citations

H-Index

Page 1

	Year	Citations
Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Alok Vyas, Prasad Dandawate, Subhash Padhyé, PubMed Medicinal ChemistryPotential Anticancer PropertiesAnti-inflammatoryChemoprevention StrategyMedicine	2013	170
Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer Prasad Dandawate, Alok Vyas, Aamir Ahmad, Pharmaceutical Research Inclusion ComplexPancreatic CancerMedicineTumor TargetingAnti-cancer Agent	2012	131
Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis Fernando F. Blanco, Ranjan Preet, Andrea Aguado, Oncotarget Crc CellsCox-2 ExpressionCancer BiologyTumor BiologyTranscriptional Regulation	2016	123
Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties Alok Vyas, Prasad Dandawate, Subhash Padhyé, Current Pharmaceutical Design Medicinal ChemistryPotential Anticancer PropertiesDried RhizomeChemoprevention StrategyAnti-inflammatory	2013	97
Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties Alok Vyas, Prasad Dandawate, Subhash Padhyé, Current Pharmaceutical Design	2013	44
Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities Shibnath Ghatak, Alok Vyas, Suniti Misra, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryCox/lox InhibitionDual Cyclooxygenase-2/5-lipoxygenase Inhibitors	2013	38
Targeting triple negative breast cancer cells by N3-substituted 9,10-Phenanthrenequinone thiosemicarbazones and their metal complexes Zahra Afrasiabi, Preston Stovall, Kristen Finley, Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy N3-substituted 9,10-PhenanthrenequinoneMedicineDrug DiscoveryCoordination ComplexAnti-cancer Agent	2013	21

Page 1